FOLH1 and neoplasm: In addition, the dynamic small PET imaging demonstrated high tumor-to-background contrast 1 hour p.i. The radiolabeled PSMA-617 also demonstrated rapid renal clearance and favorable pharmacokinetic properties, resulting in very high tumor-to-blood and tumor-to-muscle ratios of 1058 and 529, respectively.30